Cargando…

Correction: Utilization of target lesion heterogeneity for treatment efficacy assessment in late stage lung cancer

Detalles Bibliográficos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8301619/
https://www.ncbi.nlm.nih.gov/pubmed/34297782
http://dx.doi.org/10.1371/journal.pone.0255429
_version_ 1783726711265820672
collection PubMed
description
format Online
Article
Text
id pubmed-8301619
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-83016192021-07-31 Correction: Utilization of target lesion heterogeneity for treatment efficacy assessment in late stage lung cancer PLoS One Correction Public Library of Science 2021-07-23 /pmc/articles/PMC8301619/ /pubmed/34297782 http://dx.doi.org/10.1371/journal.pone.0255429 Text en © 2021 The PLOS ONE Staff https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Correction
Correction: Utilization of target lesion heterogeneity for treatment efficacy assessment in late stage lung cancer
title Correction: Utilization of target lesion heterogeneity for treatment efficacy assessment in late stage lung cancer
title_full Correction: Utilization of target lesion heterogeneity for treatment efficacy assessment in late stage lung cancer
title_fullStr Correction: Utilization of target lesion heterogeneity for treatment efficacy assessment in late stage lung cancer
title_full_unstemmed Correction: Utilization of target lesion heterogeneity for treatment efficacy assessment in late stage lung cancer
title_short Correction: Utilization of target lesion heterogeneity for treatment efficacy assessment in late stage lung cancer
title_sort correction: utilization of target lesion heterogeneity for treatment efficacy assessment in late stage lung cancer
topic Correction
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8301619/
https://www.ncbi.nlm.nih.gov/pubmed/34297782
http://dx.doi.org/10.1371/journal.pone.0255429
work_keys_str_mv AT correctionutilizationoftargetlesionheterogeneityfortreatmentefficacyassessmentinlatestagelungcancer